4 insiders bought Braveheart Bio, Inc. (BRVE) shares worth $76,019,994 on Aug 7, 2026
4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Christopher Viehbacher | P Open-market purchase | 83,333 held after: 609,519 | $18.00 | $1,499,994 | SEC filing ↗ |
| Aug 7, 2026 | Erez Chimovits | P Open-market purchase | 1,666,667 held after: 11,901,826 | $18.00 | $30,000,006 | SEC filing ↗ |
| Aug 7, 2026 | Erez Chimovits | P Open-market purchase | 273,333 held after: 273,333 | $18.00 | $4,919,994 | SEC filing ↗ |
| Aug 7, 2026 | Marc L Andreessen | P Open-market purchase | 1,100,000 held after: 10,232,420 | $18.00 | $19,800,000 | SEC filing ↗ |
| Aug 7, 2026 | Benjamin A. Horowitz | P Open-market purchase | 1,100,000 held after: 10,232,420 | $18.00 | $19,800,000 | SEC filing ↗ |
Total of the rows above: $76,019,994, in the currency the filings report.
Summary written by an AI model from the filing data above (model: gemini-3.6-flash):
On 2026-08-07, 4 actors executed open-market purchase transactions for a total of 4,223,333 shares of Braveheart Bio, Inc. totaling $76,019,994.
Across 5 trades, all shares were bought at $18.00 per share. The transactions included purchases of 83,333 shares for $1,499,994, 1,666,667 shares for $30,000,006, 273,333 shares for $4,919,994, 1,100,000 shares for $19,800,000, and 1,100,000 shares for $19,800,000.
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
